For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of UNJHA FORMUL. For more details, see the UNJHA FORMUL quarterly results and UNJHA FORMUL share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 7.4 |
No. of shares | m | 4.48 |
1 Week | % | -0.4 |
1 Month | % | 7.3 |
1 Year | % | 64.7 |
52 week H/L | Rs | 24.9/10.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
UNJHA FORMUL EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 14 | 11 | 10 | 14 | 20 | |
Low | Rs | 7 | 6 | 5 | 7 | 8 | |
Sales per share (Unadj.) | Rs | 25.5 | 23.7 | 22.2 | 31.6 | 29.4 | |
Earnings per share (Unadj.) | Rs | 0.7 | 0.7 | 0.2 | 0.6 | 0.6 | |
Diluted earnings per share | Rs | 0.7 | 0.7 | 0.2 | 0.6 | 0.6 | |
Cash flow per share (Unadj.) | Rs | 0.9 | 0.9 | 0.4 | 0.7 | 0.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 3.4 | 4.1 | 4.3 | 4.8 | 5.5 | |
Adj. book value per share | Rs | 3.4 | 4.1 | 4.3 | 4.8 | 5.5 | |
Shares outstanding (eoy) | m | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | |
Price / Sales ratio | x | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | |
Avg P/E ratio | x | 15.2 | 12.2 | 33.5 | 18.4 | 22.4 | |
P/CF ratio (eoy) | x | 11.8 | 9.7 | 18.7 | 14.1 | 17.6 | |
Price / Book Value ratio | x | 3.0 | 2.1 | 1.8 | 2.1 | 2.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 46 | 38 | 35 | 47 | 63 | |
Total wages/salary | Rs m | 4 | 4 | 4 | 5 | 4 |
UNJHA FORMUL INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 114 | 106 | 100 | 142 | 132 | |
Other income | Rs m | 1 | 3 | 2 | 2 | 0 | |
Total revenues | Rs m | 115 | 109 | 102 | 144 | 132 | |
Gross profit | Rs m | 3 | 2 | 4 | 3 | 4 | |
Depreciation | Rs m | 1 | 1 | 1 | 1 | 1 | |
Interest | Rs m | 0 | 1 | 2 | 1 | 1 | |
Profit before tax | Rs m | 3 | 3 | 3 | 3 | 3 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 2 | 0 | 0 | |
Profit after tax | Rs m | 3 | 3 | 1 | 3 | 3 | |
Gross profit margin | % | 2.6 | 2.3 | 3.7 | 2.3 | 3.3 | |
Effective tax rate | % | 0 | 0 | 68.6 | 15.7 | 14.3 | |
Net profit margin | % | 2.6 | 2.9 | 1.0 | 1.8 | 2.1 |
UNJHA FORMUL BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 25 | 26 | 24 | 24 | 23 | |
Current liabilities | Rs m | 21 | 19 | 16 | 13 | 10 | |
Net working cap to sales | % | 3.4 | 6.4 | 8.0 | 7.8 | 10.3 | |
Current ratio | x | 1.2 | 1.4 | 1.5 | 1.9 | 2.4 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 42,760,063 | 39,638,105 | 35,751,103 | 179 | 291 | |
Net fixed assets | Rs m | 11 | 11 | 11 | 11 | 11 | |
Share capital | Rs m | 45 | 45 | 45 | 45 | 45 | |
"Free" reserves | Rs m | -30 | -27 | -26 | -23 | -20 | |
Net worth | Rs m | 15 | 18 | 19 | 22 | 25 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 37 | 37 | 35 | 35 | 34 | |
Interest coverage | x | 21.0 | 3.7 | 2.9 | 3.3 | 6.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 3.1 | 2.9 | 2.8 | 4.1 | 3.9 | |
Return on assets | % | 8.6 | 11.4 | 7.8 | 11.1 | 10.0 | |
Return on equity | % | 19.9 | 17.0 | 5.4 | 11.6 | 11.5 | |
Return on capital | % | 20.9 | 23.4 | 26.1 | 19.9 | 15.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 33 | 0 | 31 | 58 | 29 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 33 | 0 | 31 | 58 | 29 |
UNJHA FORMUL CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -1 | 4 | -7 | 3 | -3 | |
From Investments | Rs m | 0 | -1 | -1 | -0 | -1 | |
From Financial Activity | Rs m | 2 | 0 | 0 | 0 | 0 | |
Net Cashflow | Rs m | 2 | 3 | -8 | 3 | -4 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Jashodaben S Patel | COMP SEC: Jigar Ray | YEAR OF INC: 1994 | BSE CODE: 531762 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare UNJHA FORMUL With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.